Cardiac impairments induced by adoptive transfer of lymphocytes from the experimental cardiomyopathy in mice

National Medical Journal of China

Volumn 85, Issue 13, 2005, Pages 892-896

  Yuan, Jing ^a   Liao, Yu Hua ^a   Wang, Zhao Hui ^a   Zhang, Jing Hui ^a   Tian, Yuan ^a   Dong, Ji Hua ^a   Wang, Jin Ping ^a  

^a UNION HOSPITAL   (China)

Author keywords

Autoimmunity; Cardiomyopathy, congestive; Lymphocytes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AUTOANTIBODY; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; MALE; MITOCHONDRION; MOUSE; MYOCARDITIS; NONHUMAN; SEROLOGY; SPLEEN LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CARDIOMYOPATHY, DILATED; HUMANS; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MYOCARDIUM; RANDOM ALLOCATION; SPLEEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 23044516358     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Liao YH, Fu M. Autoimmunity in the pathogenesis of cardiomyopathy. J Autoimmun, 2000, 16: 1-2.
2. Fu M, Matsui S. Is cardiomyopathy an autoimmune disease? Keio J Med, 2002, 51: 208-212.
3. Liao YH. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. Inter J Cardilo, 1996, 54: 165-169.
4. Schulze K, Becker BF, Schauer R, et al. Antibodies to ADP-ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation, 1990, 81: 959-969.
5. Yuan J, Wang ZH, Liao YH, et al. Effects of treatment with anti-L3T4 monoclonal antibody on the cardiomypathy induced by ANT peptide in mice. J Clin Cardiol, 2004, 3: 162-165.
6. Schwimmbeck PL, Bland NK, Schuotheiss HP, et al. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Eur Heart J, 1991, 12 (Suppl D): 76-60.
7. Xia DY, Sanders A, Shah M, et al. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation, 2001, 72: 907-914.
8. Ulett GC, Ketheesan N, Hirst RG. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infection and Immunity, 2000, 68: 2034-2042.
9. Rose NR, Bona C. Defining criteria for autoimmune disease (Witebsky' s postulates revisited). Immunol Today, 1993, 14: 426-430.
10. Neu N, Ploier B, Ofner C. Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J Immunol, 1990, 145: 4094-4100.
11. Smith SC, Allin PM. Myosin-induced acute myocarditis is a cell-mediated disease. J Immunol, 1991, 147: 2141-2147.
12. Izumi T, Takehana H, Matsuda C, et al. Experimental autoimmune myocarditis and its pathomechanism. Herz, 2000, 25: 274-278.
13. Pulkki KJ. Cytokines and cardiomyocyte death. Ann Med, 1997, 29: 339-343.